Theratechnologies Inc. (TH.TO) Closes The Sale Of Its Investment In Celmed BioSciences 
10/19/2005 5:09:19 PM

MONTREAL, June 20 /CNW Telbec/ - Theratechnologies (TSX : TH) today announced the sale of its 37% investment in Celmed BioSciences (Celmed) for total proceeds of up to $ 8.4 million. The acquirer is a group of minority shareholders of Celmed.